Cargando…

Chromosome Territories in Hematological Malignancies

Chromosomes are organized in distinct nuclear areas designated as chromosome territories (CT). The structural formation of CT is a consequence of chromatin packaging and organization that ultimately affects cell function. Chromosome positioning can identify structural signatures of genomic organizat...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Lima, Matheus Fabiao, Lisboa, Mateus de Oliveira, Terceiro, Lucas E. L., Rangel-Pozzo, Aline, Mai, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028803/ https://www.ncbi.nlm.nih.gov/pubmed/35456046 http://dx.doi.org/10.3390/cells11081368

Ejemplares similares

Chromosomal Instability in Acute Myeloid Leukemia
por: de Oliveira Lisboa, Mateus, et al.
Publicado: (2021)

Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin’s Lymphoma Cell Death
por: de Lima, Matheus Fabiao, et al.
Publicado: (2022)

Genomic Instability in Circulating Tumor Cells
por: Freitas, Monique Oliveira, et al.
Publicado: (2020)

Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies
por: Weng, Stephanie, et al.
Publicado: (2016)

Three-dimensional nuclear telomere architecture and differential expression of aurora kinase genes in chronic myeloid leukemia to measure cell transformation
por: de Oliveira, Fábio Morato, et al.
Publicado: (2022)

‘Leaky gut’ in hematological malignancies()
por: Costa-Lima, Carolina, et al.
Publicado: (2014)

Topological origins of chromosomal territories
por: Dorier, Julien, et al.
Publicado: (2009)

Chromosome Territory Modeller and Viewer
por: Tkacz, Magdalena A., et al.
Publicado: (2016)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations
por: Rangel-Pozzo, Aline, et al.
Publicado: (2020)

Chromosome Territories Meet a Condensin
por: Hirano, Tatsuya
Publicado: (2012)

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients
por: Drachenberg, Darrel, et al.
Publicado: (2019)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome
por: Laurent, Anouchka P., et al.
Publicado: (2020)

Role of Extracellular Vesicles in Hematological Malignancies
por: Raimondo, Stefania, et al.
Publicado: (2015)

Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy
por: Wark, Landon, et al.
Publicado: (2019)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes
por: Vundinti, Babu Rao, et al.
Publicado: (2011)

Telomere Shortening in Hematological Malignancies with Tetraploidization—A Mechanism for Chromosomal Instability?
por: Kjeldsen, Eigil
Publicado: (2017)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

The treatment of hematologic malignancies in pregnancy
por: Vandenbriele, C., et al.
Publicado: (2010)

Telomerase Activation in Hematological Malignancies
por: Ropio, Joana, et al.
Publicado: (2016)

Epigenetics of hematopoiesis and hematological malignancies
por: Hu, Deqing, et al.
Publicado: (2016)

Rac GTPases in Hematological Malignancies
por: Durand-Onaylı, Valerie, et al.
Publicado: (2018)

Arterial stiffness in hematologic malignancies
por: Mozos, Ioana, et al.
Publicado: (2017)

Checkpoint inhibitors in hematological malignancies
por: Ok, Chi Young, et al.
Publicado: (2017)

HMGA Proteins in Hematological Malignancies
por: Minervini, Angela, et al.
Publicado: (2020)

Intestinal Microbes and Hematological Malignancies
por: Zhu, Yinghong, et al.
Publicado: (2023)

Mitochondrial transfer in hematological malignancies
por: Guo, Xiaodong, et al.
Publicado: (2023)

CircRNAs in hematopoiesis and hematological malignancies
por: Bonizzato, A, et al.
Publicado: (2016)

Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies
por: Testa, Ugo, et al.
Publicado: (2022)

Bispecific Antibodies in the Treatment of Hematologic Malignancies
por: Duell, Johannes, et al.
Publicado: (2019)

Association of Chromosome Territories with the Nuclear Matrix: Disruption of Human Chromosome Territories Correlates with the Release of a Subset of Nuclear Matrix Proteins
por: Ma, Hong, et al.
Publicado: (1999)

Telomere-Associated Changes in Nuclear Architecture of Cancer-Associated Macrophage-like Cells in Liquid Biopsies from Melanoma Patients
por: Rangel-Pozzo, Aline, et al.
Publicado: (2022)

Gene promoters show chromosome-specificity and reveal chromosome territories in humans
por: Gagniuc, Paul, et al.
Publicado: (2013)

Chromosome–nuclear envelope attachments affect interphase chromosome territories and entanglement
por: Kinney, Nicholas Allen, et al.
Publicado: (2018)

Chromosome territory formation attenuates the translocation potential of cells
por: Rosin, Leah F, et al.
Publicado: (2019)

The Hematology of Tomorrow Is Here—Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
por: Arranz, Lorena
Publicado: (2022)

Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities
por: Han, Eunhee, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l6ahdis263s7h6bnfps15stfbm